an effect that has led to FDA approval of several GLP-1 therapies specifically for obesity
GLP-1 receptor agonists (GLP-1-RA) were first developed for the treatment of type-2 diabetes, but have been recently approved for treatment of obesity
Unlike standard grocery brands, our broth is slow-simmered for 24+ hours to ensure maximum collagen and protein density
Compounded formulations have filled some of this access gap
Modulation of DPP-4 enzymes includes teneligliptin, vildagliptin, saxagliptin, linagliptin, sitagliptin, anagliptin, alogliptin, gemigliptin, etc
This research is supported by the Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health, award # R01 HD100383.